1. Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis. Issue 3 (September 2019) Authors: Faje, Alexander; Reynolds, Kerry; Zubiri, Leyre; Lawrence, Donald; Cohen, Justine V; Sullivan, Ryan J; Nachtigall, Lisa; Tritos, Nicholas Journal: European journal of endocrinology Issue: Volume 181:Issue 3(2019) Page Start: 211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. RADT-24. PHASE II STUDY OF PROTON RADIATION THERAPY FOR LOWER GRADE GLIOMAS. (14th November 2022) Authors: Slater, Jason; Horick, Nora; Nachtigall, Lisa; Parsons, Michael; Zarrella, Giuliana; Tritos, Nicholas; Dietrich, Jorg; Pursley, Jennifer; Fullerton, Barbara; Wang, Irene; Oh, Kevin; Loeffler, Jay; Yeap, Beow; Shih, Helen Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗